UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024171
Receipt number R000023451
Scientific Title The study on renal excretion drug dosage adjustment by point of care test in community pharmacy
Date of disclosure of the study information 2016/10/01
Last modified on 2019/04/01 10:40:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study on renal excretion drug dosage adjustment by point of care test in community pharmacy

Acronym

The study on proper use of medicine by point of care test in community pharmacy

Scientific Title

The study on renal excretion drug dosage adjustment by point of care test in community pharmacy

Scientific Title:Acronym

The study on proper use of medicine by point of care test in community pharmacy

Region

Japan


Condition

Condition

Herpes zoster, Chronic Kidney disease

Classification by specialty

Medicine in general Nephrology Geriatrics
Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Pharmacokinetics are often altered in CKD patients.In particular, the optimal dosages of renally excreted drugs are strongly affected by renal impairment. Dosages that do not take renal function into account are a major cause of increases in drug blood concentrations that lead to adverse drug events. Appropriate dosages of renally excreted drugs can be calculated on the basis of renal function using creatinine clearance. Thus, dosage adjustment based on renal function contributes to a reduction in the incidence of adverse drug events in older patients and others with renal impairment. Adjustment of the drug dosage according to renal function (ADDR) by pharmacists, as a result of checking renal function and recommending alterations in their prescriptions, can prevent inappropriate dosages and thus reduce the incidence of the resulting adverse drug events.
However, there is insufficient implementation of ADDR by community pharmacists and to check prescriptions for patients with renal impairment and to implement ADDR.
In particular,most community pharmacists indicated that the most frequent obstacle to implementing ADDR was "Difficulty in obtaining information on patient renal function".
The aims of this study were to investigate the efficacy of renal function point of care testing for prevention of renally excreted drugs overdose.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The number of avoidance of renally excreted drugs overdose

Key secondary outcomes

Reduction of drug cost
Frequency of adverse drug event


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Medicine Other

Interventions/Control_1

Serum creatinine point of care testing

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients over 65 and/or had suspection of renal insufficiency

The patients are prescribed aciclovir, valaciclovir, or famciclovir

Key exclusion criteria

Dialysis patient
The patients taking anticoagulants
The patients are prone to bleeding
The patients who are unable to self-collect the blood sample

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuki Kondo

Organization

Graduate School of Pharmaceutical Sciences, Kumamoto University

Division name

Department of Clinical Chemistry and Informatics

Zip code


Address

5-1 Oe-honmachi, Chuo-ku, Kumamoto, Japan

TEL

096-371-4559

Email

ykondo@kumamoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuki Kondo

Organization

Graduate School of Pharmaceutical Sciences, Kumamoto University

Division name

Department of Clinical Chemistry and Informatics

Zip code


Address

5-1 Oe-honmachi, Chuo-ku, Kumamoto, Japan

TEL

096-371-4559

Homepage URL


Email

ykondo@kumamoto-u.ac.jp


Sponsor or person

Institute

Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

Kumamoto University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Takuma central pharmacy

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

託麻中央薬局(熊本県)


Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 01 Day

Date of IRB

2015 Year 11 Month 26 Day

Anticipated trial start date

2016 Year 10 Month 01 Day

Last follow-up date

2019 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 26 Day

Last modified on

2019 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023451


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name